These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 7145776)

  • 41. In vitro activity of rosoxacin against Haemophilus influenzae.
    Jurek EA; Weiner LB; Granato PA
    Chemotherapy; 1983; 29(4):262-4. PubMed ID: 6603337
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Acrosoxacin (rosoxacin) sensitivity of Neisseria strains].
    Fuzi M
    Orv Hetil; 1984 Apr; 125(17):1005-7. PubMed ID: 6425763
    [No Abstract]   [Full Text] [Related]  

  • 43. Treatment of uncomplicated gonorrhea with rosoxacin.
    Limsuwan A; Siristhonpun Y; Srimoung S; Gherunpong V; Arya G
    J Med Assoc Thai; 1983 Dec; 66(12):770-4. PubMed ID: 6676439
    [No Abstract]   [Full Text] [Related]  

  • 44. [In vitro effect of rosoxacin on hospital bacteria. Results of a multicenter study].
    Soussy CJ; Le Van Thoi J; Chanal M; Cluzel M; Fleurette J; Forey F; Thabaut A; Meyran M; Vandekerkove M; Sicard D; Acar JF; Kitzis MD; Veron M; Fauchere JL
    Pathol Biol (Paris); 1983 Jun; 31(6):504-8. PubMed ID: 6348657
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Current concepts in the treatment of urinary tract infections and prostatitis.
    Childs SJ
    Am J Med; 1991 Dec; 91(6A):120S-123S. PubMed ID: 1767801
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Concentration of ofloxacin in canine prostate tissue and prostate fluid after intraprostatic injection of biodegradable sustained-releasing microspheres containing ofloxacin.
    Bahk JY; Hyun JS; Lee JY; Kim J; Cho YH; Lee JH; Park JS; Kim MO
    J Urol; 2000 May; 163(5):1560-4. PubMed ID: 10751888
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Is fosfomycin a potential treatment alternative for multidrug-resistant gram-negative prostatitis?
    Gardiner BJ; Mahony AA; Ellis AG; Lawrentschuk N; Bolton DM; Zeglinski PT; Frauman AG; Grayson ML
    Clin Infect Dis; 2014 Feb; 58(4):e101-5. PubMed ID: 24170195
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Intraprostatic distribution of lomefloxacin following multiple-dose administration.
    Kovarik JM; de Hond JA; Hoepelman IM; Boon T; Verhoef J
    Antimicrob Agents Chemother; 1990 Dec; 34(12):2398-401. PubMed ID: 2088193
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [In vitro activity of rosoxacin (Win 35 213) against Neisseria gonorrhoeae (author's transl)].
    Braveny I; Machka K
    Arzneimittelforschung; 1980; 30(9):1476-8. PubMed ID: 6779824
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Diffusion of piperacillin, cefotiam, minocycline, amikacin and ofloxacin into the prostate.
    Goto T; Makinose S; Ohi Y; Yamauchi D; Kayajima T; Nagayama K; Hayami H
    Int J Urol; 1998 May; 5(3):243-6. PubMed ID: 9624555
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Penetration of a single infusion of ampicillin and sulbactam into prostatic tissue during transurethral prostatectomy.
    Klotz T; Braun M; Bin Saleh A; Orlovski M; Engelmann U
    Int Urol Nephrol; 1999; 31(2):203-9. PubMed ID: 10481965
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Antibiotic therapy--rationale and evidence for optimal drug concentrations in prostatic and seminal fluid and in prostatic tissue.
    Naber KG; Sörgel F
    Andrologia; 2003 Oct; 35(5):331-5. PubMed ID: 14535866
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Single oral dose rosoxacin in the treatment of gonorrhoea in males.
    Limson BM; Macasaet RK
    J Int Med Res; 1982; 10(1):42-5. PubMed ID: 6800861
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Norfloxacin in prostatitis: correlation between HPLC tissue concentrations and clinical results.
    Bologna M; Vaggi L; Flammini D; Carlucci G; Forchetti CM
    Drugs Exp Clin Res; 1985; 11(2):95-100. PubMed ID: 3836122
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effects of quinolones on mitogen-stimulated human mononuclear leucocytes.
    Manzella JP; Clark JK
    J Antimicrob Chemother; 1988 Feb; 21(2):183-6. PubMed ID: 3360681
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Penetration of lomefloxacin into human prostatic tissue.
    Leroy A; Grise P; Dhib M; Valtchev B; Fillastre JP
    Urology; 1991 Aug; 38(2):192. PubMed ID: 1877143
    [No Abstract]   [Full Text] [Related]  

  • 57. A comparative study of the distribution of ofloxacin and ciprofloxacin in prostatic tissues after simultaneous oral ingestion.
    Png JC; Tan E; Foo KT; Li MK; Cheng C; Rekhraj IR
    Br J Urol; 1997 May; 79(5):781-4. PubMed ID: 9158519
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Management of acute gonorrhea in males with Rosoxacin].
    Fischer-Brügge U; Reinel D
    Dtsch Med Wochenschr; 1985 Jul; 110(28-29):1115-8. PubMed ID: 3924547
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Sensitivity of gonococci to rosoxacin compared with that of penicillin, cefuroxime and tetracycline.
    Seth AD
    J Antimicrob Chemother; 1981 Apr; 7(4):331-4. PubMed ID: 6788746
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Further observations on the effect of rosoxacin in men with gonorrhea].
    Stapiński A; Gede K; Dajek Z; Szreder I; Owsińska H; Kamiński A; Wójtowicz U; Selibórska Z
    Przegl Dermatol; 1988; 75(4):314-9. PubMed ID: 3070638
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.